The FDA has ordered a phaseout of knockoffs for these blockbuster weight-loss drugsThe FDA's decision will phase out off-brand copies of obesity and diabetes drugs, affecting access and pricing for consumers.
Americans seeking Eli Lilly and Novo Nordisk's weight-loss drugs turn to compounded marketPatients are struggling to obtain weight-loss and diabetes medications due to supply issues and insurance problems, turning instead to cheaper online alternatives.
Patients Are Suing Over Alleged Side Effects of Weight-Loss DrugsBarber's experience with Ozempic led to severe health issues, including gastroparesis, raising concerns about the drug's long-term effects.
Mounjaro Patients Show Hugely Improved Blood PressureTirzepatide, a rival to semaglutide, has been shown to improve blood pressure after 36 weeks of use.Tirzepatide is already approved as a weight loss drug under the name Zepbound and as a diabetes medication under the name Mounjaro.